Literature DB >> 9797361

Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study.

K W Nuako1, D A Ahlquist, D W Mahoney, D J Schaid, D M Siems, N M Lindor.   

Abstract

BACKGROUND & AIMS: Familial predisposition as a risk for colorectal cancer in ulcerative colitis has not been rigorously explored. The aim of this study was to compare colorectal cancer frequency among kindreds of patients who had ulcerative colitis and colorectal cancer with that of control patients who had ulcerative colitis but no cancer.
METHODS: Questionnaires were mailed to subjects to assess cancer occurrence among relatives. Eligible cases included 174 ulcerative colitis patients with colorectal cancer seen at Mayo Clinic in 1976-1994; 174 contemporaneous ulcerative colitis controls without cancer were matched on birth year, sex, and extent and duration of colitis.
RESULTS: The responding 147 case and 150 control subjects reported on 1044 and 1090 first-degree relatives, respectively. Colorectal cancer occurred in 14.3% case kindreds and 6.7% control kindreds (P = 0.03). By logistic regression, a family history of sporadic colorectal cancer was an independent risk factor for cancer in ulcerative colitis (odds ratio, 2.33; 95% confidence interval, 1.06-5.14; P = 0.03).
CONCLUSIONS: A familial association exists between colorectal cancers occurring with ulcerative colitis and those in the general population. Colorectal cancer in persons with ulcerative colitis represents a risk factor for colorectal cancer in their noncolitic relatives. Likewise, a family history of sporadic colorectal cancer increases the risk of colorectal cancer with ulcerative colitis.

Entities:  

Mesh:

Year:  1998        PMID: 9797361     DOI: 10.1016/s0016-5085(98)70077-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  50 in total

Review 1.  Cancer surveillance in inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  1999-12

Review 2.  The approach to dysplasia surveillance in inflammatory bowel disease.

Authors:  Remo Panaccione
Journal:  Can J Gastroenterol       Date:  2006-04       Impact factor: 3.522

Review 3.  Infection, inflammation, and gastrointestinal cancer.

Authors:  C R Boland; M G Luciani; C Gasche; A Goel
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

4.  Surveillance for colitis-associated colon neoplasia.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 5.  Inflammatory bowel disease: the problems of dysplasia and surveillance.

Authors:  P J Mitchell; E Salmo; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2007-11-30       Impact factor: 3.781

6.  The cancer "fear" in IBD patients: is it still REAL?

Authors:  T M Connelly; W A Koltun
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

7.  Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis.

Authors:  Francesco Azzolini; Cristiano Pagnini; Lorenzo Camellini; Antonella Scarcelli; Alberto Merighi; Anna Maria Primerano; Angela Bertani; Aldo Antonioli; Federico Manenti; Gian Piero Rigo
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 8.  Endoscopic and pathological aspects of colitis-associated dysplasia.

Authors:  Fiona D M van Schaik; G Johan A Offerhaus; Marguerite E I Schipper; Peter D Siersema; Frank P Vleggaar; Bas Oldenburg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-22       Impact factor: 46.802

Review 9.  Colorectal cancer in inflammatory bowel disease: review of the evidence.

Authors:  D S Keller; A Windsor; R Cohen; M Chand
Journal:  Tech Coloproctol       Date:  2019-01-30       Impact factor: 3.781

Review 10.  Cancer in inflammatory bowel disease.

Authors:  Jianlin Xie; Steven H Itzkowitz
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.